Oculis Holding AG (OCS) stock
OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 4, 2026Score 1/30
$7.51−0.12 (-1.57%)
Close on Nov 17, 2026Market cap $451.27MP/E –Yield –
Oculis enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Oculis's enterprise value was $322.36M on Nov 11, 2026, against $687.75M a year earlier. Over the last 5 years it ranged from -$25.34M to $1.33B, with a median of $314.64M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $322.36M | -55.6% |
| 2025 | Dec 31, 2025 | $725.94M | +57.8% |
| 2024 | Dec 31, 2024 | $459.94M | +3025.1% |
| 2023 | Dec 29, 2023 | $14.72M | – |
| 2022 | Dec 30, 2022 | -$22.02M | -212.5% |
| 2021 | Dec 31, 2021 | $19.58M | – |
See a number that looks wrong?